BACKGROUNDMonoclonal antibodies (mAb) are antibodies that are made by identical immune cells derived from a unique parent B lymphocyte cell. During the past few decades, mAbs have become an integral and widely used technology for both laboratory diagnostics and clinical treatment. As it the case for many other prescription drugs, it is necessary to perform clinical laboratory tests before and after the treatment with therapeutic mAb to screen for potentially sensitive patients, check the patients’ background health status and to evaluate the response to treatment. It has also been reported that some mAbs may interfere with clinical laboratory tests, especially diagnostic kits that use mAb to detect a specific analyte. However, to the best of our knowledge, there have not been any systematic review about the clinical laboratory tests needed for and affected by therapeutic mAb based on the drug labels.Drug labels provide an excellent source of data for pharmacoepidemiological studies because they contain detailed information about the individual drugs. Therefore, we reviewed and analyzed all the labels of FDA‐approved therapeutic mAbs deposited in DailyMed, the official website for FDA‐approved drug labels (https://dailymed.nlm.nih.gov/dailymed/index.cfm), to provide a detailed profile of the clinical laboratory tests which should be performed before, during
Journal of Clinical Laboratory Analysis – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera